AU2001254692A1 - 2-phenylpyran-4-one derivatives - Google Patents

2-phenylpyran-4-one derivatives

Info

Publication number
AU2001254692A1
AU2001254692A1 AU2001254692A AU5469201A AU2001254692A1 AU 2001254692 A1 AU2001254692 A1 AU 2001254692A1 AU 2001254692 A AU2001254692 A AU 2001254692A AU 5469201 A AU5469201 A AU 5469201A AU 2001254692 A1 AU2001254692 A1 AU 2001254692A1
Authority
AU
Australia
Prior art keywords
group
alkyl
methanesulfonylphenyl
pyran
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001254692A
Other languages
English (en)
Inventor
Maria Isabel Crespo Crespo
Joan Feixas Gras
Juan Miguel Jimenez Mayorga
Josep Lluis Matallana Julia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall AG
Original Assignee
Almirall Prodesfarma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Prodesfarma SA filed Critical Almirall Prodesfarma SA
Publication of AU2001254692A1 publication Critical patent/AU2001254692A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
AU2001254692A 2000-03-16 2001-03-16 2-phenylpyran-4-one derivatives Abandoned AU2001254692A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200000637 2000-03-16
ES200000637 2000-03-16
PCT/EP2001/003042 WO2001068633A1 (en) 2000-03-16 2001-03-16 2-phenylpyran-4-one derivatives

Publications (1)

Publication Number Publication Date
AU2001254692A1 true AU2001254692A1 (en) 2001-09-24

Family

ID=8492732

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001254692A Abandoned AU2001254692A1 (en) 2000-03-16 2001-03-16 2-phenylpyran-4-one derivatives

Country Status (27)

Country Link
US (1) US7354936B2 (cs)
EP (1) EP1263751B1 (cs)
JP (1) JP2003527389A (cs)
KR (1) KR20030005221A (cs)
CN (1) CN1429221A (cs)
AR (1) AR030410A1 (cs)
AT (1) ATE269316T1 (cs)
AU (1) AU2001254692A1 (cs)
BG (1) BG107101A (cs)
BR (1) BR0109252A (cs)
CA (1) CA2403149A1 (cs)
CZ (1) CZ20023058A3 (cs)
DE (1) DE60103859T2 (cs)
EE (1) EE200200528A (cs)
ES (1) ES2223830T3 (cs)
HK (1) HK1048117A1 (cs)
HU (1) HUP0301696A2 (cs)
IL (1) IL151598A0 (cs)
MX (1) MXPA02009016A (cs)
NO (1) NO20024393L (cs)
NZ (1) NZ521187A (cs)
PE (1) PE20011333A1 (cs)
PL (1) PL358062A1 (cs)
RU (1) RU2002127728A (cs)
SK (1) SK12832002A3 (cs)
WO (1) WO2001068633A1 (cs)
ZA (1) ZA200207184B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465509B2 (en) 2000-06-30 2002-10-15 Merck Frosst Canada & Co. Pyrones as inhibitors of cyclooxygenase-2
ES2213485B1 (es) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
CN102731456B (zh) * 2011-04-01 2014-07-09 华中科技大学 一种抗肿瘤化合物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH524612A (de) 1969-12-31 1972-06-30 Ciba Geigy Ag Verfahren zur Herstellung von neuen Imidazolderivaten
US3901908A (en) * 1970-12-28 1975-08-26 Ciba Geigy Corp 2-alkyl- and 2-cycloalkyl-4,5-bis-phenyl-imidazoles
ES490122A0 (es) 1979-04-05 1981-04-01 Lilly Industries Ltd Procedimiento para preparar piranonas 5-sustituidas
US4304728A (en) * 1979-04-05 1981-12-08 Lilly Industries Limited 6-Substituted pyranone compounds and their use as pharmaceuticals
US6048850A (en) * 1992-09-22 2000-04-11 Young; Donald A. Method of inhibiting prostaglandin synthesis in a human host
SK63996A3 (en) * 1993-11-19 1996-11-06 Parke Davis & Co Pyrone derivatives as protease inhibitors and antiviral agents
US5521213A (en) 1994-08-29 1996-05-28 Merck Frosst Canada, Inc. Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
US5541204A (en) 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
HUP9801602A3 (en) 1995-04-04 1999-01-28 Glaxo Group Ltd Imidazo[1,2-a]pyridine derivatives, process for their production, pharmaceutical compositions and use thereof
CN1142148C (zh) 1997-11-19 2004-03-17 兴和株式会社 新颖的哒嗪衍生物和含有其作为有效成分的药物
TW587079B (en) * 1998-09-25 2004-05-11 Almirall Prodesfarma Ag 2-phenylpyran-4-one derivatives

Also Published As

Publication number Publication date
BG107101A (bg) 2003-07-31
JP2003527389A (ja) 2003-09-16
HUP0301696A2 (hu) 2003-09-29
ZA200207184B (en) 2003-12-08
EE200200528A (et) 2004-04-15
PL358062A1 (en) 2004-08-09
CN1429221A (zh) 2003-07-09
SK12832002A3 (sk) 2003-11-04
BR0109252A (pt) 2002-12-24
DE60103859D1 (de) 2004-07-22
RU2002127728A (ru) 2004-03-20
US7354936B2 (en) 2008-04-08
DE60103859T2 (de) 2005-07-21
IL151598A0 (en) 2003-04-10
NZ521187A (en) 2004-03-26
NO20024393D0 (no) 2002-09-13
PE20011333A1 (es) 2002-01-16
ATE269316T1 (de) 2004-07-15
NO20024393L (no) 2002-11-13
CZ20023058A3 (cs) 2004-01-14
AR030410A1 (es) 2003-08-20
EP1263751A1 (en) 2002-12-11
EP1263751B1 (en) 2004-06-16
ES2223830T3 (es) 2005-03-01
HK1048117A1 (zh) 2003-03-21
KR20030005221A (ko) 2003-01-17
WO2001068633A1 (en) 2001-09-20
CA2403149A1 (en) 2001-09-20
US20030232880A1 (en) 2003-12-18
MXPA02009016A (es) 2004-10-15

Similar Documents

Publication Publication Date Title
JP3251945B2 (ja) 選択的シクロオキシゲナーゼ−２阻害物質となる置換ピリジン
ATE473206T1 (de) Phenacylamin-derivate, ihre herstellung und seuchenmittel, die diese derivate enthalten
PL162219B1 (pl) Sposób wytwarzania nowych pochodnych kwasu propenowego PL PL PL PL PL PL
DE69733135D1 (de) Substituierte imidazole mit cytokinin-inhibirender wirkung
IL98830A (en) History of pyrimidine, process for their preparation and compositions of fungicides containing them
RU92004433A (ru) Ароматические аминоспиртовые производные, способ их получения и фармацевтическая композиция
BR0313340A (pt) Composto, processo de preparação de composto, composição fungicida e método de combate preventivo ou curativo de fungos fitopatogênicos de safras
GB9800569D0 (en) Heterocyclic compounds
FI925255A (fi) Aromatiska amino-alkoholderivat med egenskaper som motverkar sockersjuka och fetma, deras framstaellning och terapeutiska anvaendningar
DK1136474T3 (da) 1-Acetyl-5-brom-4,6-dimethylindolin
JP2001517654A (ja) Ｃｏｘ−２のインヒビターとして有用なジアリールピリジンの製造方法
PT88772B (pt) Processo para a preparacao de derivados do acido propenoico e de composicoes fungicidas que os contem
WO1999014194A1 (en) 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
NO984195L (no) Nye benzofuranonderivater og deres fremstilling
AU690990B2 (en) Insecticidal N,N'-disubstituted-N-N'-diacylhydrazines
AU2001254692A1 (en) 2-phenylpyran-4-one derivatives
RU2001111323A (ru) Производные 2-фенилпиран-4-она
KR910005893B1 (ko) 제초제 5-아미노-3-옥소-4-(치환된-페닐)-2,3-디하이드로푸란 및 그 유도체의 제조방법
CA2301590C (en) 2-aminopyridines as inhibitors of cyclooxygenase-2
CA2307853A1 (en) Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors
DE68924416D1 (de) Carboximidamid-Derivate.
KR900005699B1 (ko) 제초제의 5-아미노-3-옥소-4-(치환된-페닐)-2,3-디히드로티오펜 및 그의 유도체
DK0979820T3 (da) 2-phenylpyridinderivater og fremgangsmåder til deres fremstilling
KR870011092A (ko) -3아미노-디히드로피리딘, 그의 제조방법 및 의약품에 있어서 그의 용도
PL162220B1 (pl) Sposób wytwarzania nowych pochodnych kwasu propenowego PL